
Please try another search
Investing.com - Goldman Sachs has raised its price target on Dr. Reddy's Laboratories Ltd. (DRRD:IN) (NYSE:RDY) to INR1,200 from INR1,175 while maintaining a Neutral rating on the stock. The...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review